维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Hellemons"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Adalimumab for Crohn’s disease: Long-term sustained benefit in a population-based cohort of 438 patients显示文摘	Charlotte P. Peters Emma J. Eshuis Florien M. Toxopeüs Merel E. Hellemons Jeroen M. Jansen Geert R.A.M. D’Haens Paul Fockens Pieter C.F. Stokkers Hans A.R.E. Tuynman Adriaan A. van Bodegraven Cyriel Y. Ponsioen	2014	Journal of Crohn’s and Colitis2014，，：	2
2	Synergistic actions of nisin,sublethal ultrahigh pressure,and reduced temperature on bacteria and yeast显示文摘	Ter Steeg P F Hellemons J C Kok A E	1999	Appl Environ Microbiol1999，65，：	1
3	Validity of biomarkers predicting onset or progression of ne- phropathy in patients with type 2 diabetes:a systematic review 显示文摘	HELLEMONS M E KERSCHBAUM J BANKER S J	2012	Diabet Med2012，29，5：	1
4	Synergistic actions of nisin, sublethal ultrahigh pressure, and reduced temperature on bacteria and yeast显示文摘	Ter Steeg P F Hellemons J C & Kok A E	1999	Applied and Environmental Microbiology1999，65，9：	1
5	Physiological and mathematical aspects in setting criteria for decontamination of foods by physical means显示文摘	SMELT J P P M HELLEMONS J C WOUTERS P C et al	2002	International Journal of Food Microbiology2002，，78：	1
6	Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes:a systematic review显示文摘	Hellemons ME Kerschbaum J Bakker SJ		0，，5：	1
7	Expression patterns of semaphoring7A and plexinC1 during rat neural development suggest roles in axon guidance and neuronal migration显示文摘	Pasterkamp R J Kolk S M Hellemons A J	2007	BMC Dev Biol2007，7，：	1
8	A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus 显示文摘	Roscioni SS de Zeeuw D Hellemons ME	2013	Diabetologia2013，56，2：	1
9	Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: A systematic review显示文摘	Hellemons M E Kerschbaum J Bakker S J	2012	Diabet Med2012，29，5：	1
10	Validity of biomarkers predicting onset or progression of nephropathy in patients with type 2 di- abetes:a systematic review显示文摘	Hellemons ME Kerschbaum J Bakker SJ	2012	Diabet Med2012，29，5：	1
11	Validity of bio- markers predicting onset or progression of nephropathy in patients with type 2 diabetes: A systematic rcview显示文摘	Hellemons ME Kerschbaum J Bakker SJ	2012	Diabet Med2012，29，5：	1
12	Initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial显示文摘	Hellemons ME Persson F Bakker SJ	2011	Diabetes Care2011，34，9：	1
13	Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomized controlled trial comparing two intensities of coumarin with aspirin显示文摘	Hellemons BS Langenberg M Lodder J	1999	BMJ1999，319，：	1
14	A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus显示文摘	Roscioni SS de Zeeuw D Hellemons ME	2013	Diabetologia2013，56，2：	1
15	Initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria:a post hoc analysis of the IRMA-2 trial显示文摘	HELLEMONS ME PERSSON F BAKKER SJ	2011	Diabetes Care2011，34，9：	1
16	alidity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review显示文摘	Hellemons ME Kerschbaum J Bakker SJ	2012	Diabet Med2012，29，5：	1
17	Validity of bio- markers predicting onset or progression of nephropathy in pa- tients with Type 2 diabetes, A systematic review显示文摘	Hellemons ME Kerschbaum J Bakker S J	2012	Diabet Med2012，29，5：	1
18	Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in Patients With Type 2 Diabetes显示文摘	Hellemons Merel E Mazagova Magdalena Gansevoort Ron T Henning Robert H de Zeeuw Dick Bakker Stephan J L Lambers-Heerspink Hiddo J Deelman Leo E	2012	Diabetes Care2012，，11：	1
19	Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes:a systematic review显示文摘	Hellemons ME Kerschbaum J Bakker S J	2012	Diabet Med2012，29，5：	1
20	Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes:a systematic review显示文摘	Hellemons ME Kerschbaum J Bakker S J	2012	Diabet Med2012，29，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示